Product Images Oxcarbazepine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 17 images provide visual information about the product associated with Oxcarbazepine NDC 69452-125 by Bionpharma Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Carton - carton

Carton - carton

This is a description of Oxcarbazepine, an oral suspension medication. It is distributed by Bionpharma in Princeton. It must be shaken before use and used within 7 weeks of first opening. It is important to dispense a medication guide to each patient. Each 5 mL contains 300 mg of Oxcarbazepine, USP. The medication must be stored below 30°C and kept away from children. Dosage information is available in the package insert.*

Structural formula - image01

Structural formula - image01

image 5 - image010

image 5 - image010

image 6 - image011v2

image 6 - image011v2

image 7 - image012v2

image 7 - image012v2

image 8 - image013v2

image 8 - image013v2

image 9 - image014v2

image 9 - image014v2

image 10 - image015v2

image 10 - image015v2

Figure 1 - image02

Figure 1 - image02

This appears to be a table with three columns. The third column contains two groups, "Oxcarbazeping" and "Placebo", likely for a study or clinical trial. The first column has a header that reads "Log-rarkcres", though it is unclear what this refers to. The second column may have to do with the timing of measurements or observations, as it contains a "Time on Tl fom Dy (8ays)" header. Beyond this, the text is not very clear.*

Figure 2 - image03

Figure 2 - image03

Figure 3 - image04

Figure 3 - image04

Figure 4 - image05

Figure 4 - image05

image 1 - image06

image 1 - image06

image 2 - image07v2

image 2 - image07v2

image 3 - image08

image 3 - image08

image 4 - image09

image 4 - image09

image description - revisedimage016

image description - revisedimage016

BIONPHARMA manufactures an oral suspension medication called Oxcarbazepine. The medication is packed in a bottle of 250 ml and its NDC is 69452-125-50. Pharmacists are advised to dispense a Medication Guide enclosed with the medication to each patient. It is important to shake the bottle well before using. The medication should be used within 7 weeks of first opening the bottle. The label suggests that this is a prescription-only medication manufactured by BIONPHARMA located in Princeton, NJ 08540.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.